Skip to main content
MetaHistoryBook
Browse
Today
Discover
Create
Language
English
Cymraeg
Loading…
Epstein–Barr virus infection — MetaHistoryBook
Epstein–Barr virus infection
Human disease
Wikipedia ↗
Wikidata (Q5384031) ↗
Details
Instance of
rare disease
,
type of disease
Subclass of
rare genetic disease
,
Herpesviridae infectious disease
disease transmission process
airborne transmission
,
placental transmission
,
haemocontact transmission of pathogen
drug or therapy used for treatment
penciclovir
,
aciclovir
genetic association
IRF8
has cause
Epstein–Barr virus
has effect
Burkitt lymphoma
,
infectious mononucleosis
,
nasopharynx carcinoma
,
chronic active EBV infection
,
Epstein–Barr virus-positive DLBCL, NOS
,
Epstein-Barr virus-associated lymphoproliferative diseases
health specialty
infectious diseases
medical examination
polymerase chain reaction
,
ELISA
,
complete blood count
,
physical examination
topic's main category
Category:Epstein–Barr virus–associated diseases
Connected on Wikidata
Subject of
Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)
The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis
Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
Comparison of Technics for Determination of Epstein-Barr Virus Serological Diagnosis
Tabelecleucel in Combination With Pembrolizumab in Subjects With EBV+ Nasopharyngeal Carcinoma (ATA129-NPC-202)
Interleukin 6 Blockade Modifying Antibody-Mediated Graft Injury and Estimated Glomerular Filtration Rate (eGFR) Decline
Phase 1-2a Study of EBNA1 Inhibitor, VK-2019, in Patients With Epstein-Barr Virus-positive Nasopharyngeal Cancer
ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus
Her2 and TGFBeta Cytotoxic T Cells in Treatment of Her2 Positive Malignancy
Genetic Studies of Chronic Active Epstein-Barr Disease
Nothing in the MetaHistoryBook collection references this item yet.
Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial